Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy

Oncology Reports

Volumn 19, Issue 3, 2008, Pages 729-735

  Yamada, Hideki ^a   Iinuma, Hisae ^a   Watanabe, Toshiaki ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 fluorouracil; Colorectal cancer; Dihydropyrimidine dehydrogenase; Orotate phosphoribosyl transferase; Thymidylate phosphorylate; Thymidylate synthase

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; FOLINIC ACID; PHOSPHORIBOSYLTRANSFERASE; THYMIDINE PHOSPHATE; THYMIDYLATE SYNTHASE; UFT; UFT PLUS LEUCOVORIN; UNCLASSIFIED DRUG;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME;

EID: 40249113752     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.3.729     Document Type: Article

References (30)